Enhabit, Inc. (NYSE:EHAB) Receives Consensus Recommendation of “Hold” from Analysts

Enhabit, Inc. (NYSE:EHABGet Free Report) has been assigned a consensus rating of “Hold” from the six analysts that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and one has assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $8.75.

Several brokerages have recently issued reports on EHAB. Jefferies Financial Group upgraded shares of Enhabit from a “hold” rating to a “buy” rating and raised their price objective for the stock from $8.25 to $9.50 in a research note on Monday, December 9th. Leerink Partners restated a “market perform” rating and issued a $8.00 price target (down from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th.

View Our Latest Report on Enhabit

Enhabit Stock Down 0.6 %

Enhabit stock opened at $7.72 on Wednesday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46. Enhabit has a fifty-two week low of $6.85 and a fifty-two week high of $11.74. The firm has a fifty day moving average price of $7.78 and a two-hundred day moving average price of $8.15. The firm has a market cap of $388.19 million, a price-to-earnings ratio of -3.33 and a beta of 1.82.

Enhabit (NYSE:EHABGet Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.01). The business had revenue of $253.60 million for the quarter, compared to analyst estimates of $261.69 million. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. During the same period in the prior year, the firm posted $0.03 EPS. As a group, analysts forecast that Enhabit will post 0.22 earnings per share for the current year.

Insider Activity

In related news, Director Jeffrey Bolton bought 4,000 shares of the company’s stock in a transaction dated Thursday, December 12th. The stock was acquired at an average cost of $8.69 per share, with a total value of $34,760.00. Following the acquisition, the director now owns 98,144 shares in the company, valued at approximately $852,871.36. This represents a 4.25 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Stuart M. Mcguigan purchased 15,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 10th. The stock was bought at an average cost of $8.81 per share, for a total transaction of $132,150.00. Following the purchase, the director now owns 46,810 shares in the company, valued at $412,396.10. This represents a 47.15 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 1.90% of the company’s stock.

Institutional Investors Weigh In On Enhabit

A number of hedge funds have recently made changes to their positions in the company. Jane Street Group LLC grew its stake in Enhabit by 514.3% during the third quarter. Jane Street Group LLC now owns 901,084 shares of the company’s stock worth $7,119,000 after buying an additional 754,395 shares during the last quarter. Marshall Wace LLP bought a new stake in Enhabit during the 2nd quarter worth approximately $1,941,000. Systematic Financial Management LP increased its holdings in Enhabit by 12.2% during the 3rd quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company’s stock valued at $14,522,000 after purchasing an additional 199,235 shares in the last quarter. DekaBank Deutsche Girozentrale raised its position in Enhabit by 52.3% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 518,412 shares of the company’s stock valued at $4,306,000 after purchasing an additional 178,000 shares during the last quarter. Finally, Bardin Hill Management Partners LP boosted its stake in Enhabit by 927.4% in the third quarter. Bardin Hill Management Partners LP now owns 174,304 shares of the company’s stock worth $1,377,000 after purchasing an additional 157,338 shares in the last quarter.

About Enhabit

(Get Free Report

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Further Reading

Analyst Recommendations for Enhabit (NYSE:EHAB)

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.